In vivo evidence for endothelin-1-mediated attenuation of α1-adrenergic stimulation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 3, 2006, Pages

  D'Angelo, Gerard ^a   Pollock, Jennifer S ^a   Pollock, David M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Salt sensitive hypertension; Sympathetic nervous system; Vascular smooth muscle

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ATRASENTAN; ENDOTHELIN 1; NORADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; ANIMAL; BLOOD PRESSURE; DAHL SALT SENSITIVE RAT; EXERCISE TEST; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; ENDOTHELIN-1; EXERCISE TEST; MALE; RATS; RATS, INBRED DAHL; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 33645731971     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00203.2005     Document Type: Article

References (34)

1. Arai H, Hori S, Aramori I, Ohkubo H, and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
2. A receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. Hypertension 31: 499-504, 1998.
3. A receptor. Am J Physiol Heart Circ Physiol 288: H1829-H1835, 2005.
4. d'Uscio LV, Barton M, Shaw S, Moreau P, and Lüscher TF. Structure and function of small arteries in salt-induced hypertension. Effects of chronic endothelin-subtype-A-receptor blockade. Hypertension 30: 905-911, 1997.
5. Damon DH. Endothelin and post-ganglionic sympathetic neurons. Clin Exp Pharmacol Physiol 26: 1000-1003, 1999.
6. De Nucci G, Thomas R, D'Orléans-Juste P, Antunes E, Walder C, Warner TD, and Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797-9800, 1988.
7. DiBona GF and Jones SY. Analysis of renal sympathetic nerve responses to stress. Hypertension 25: 531-538, 1995.
8. Doucet J, Gonzalez W, and Michel JB. Endothelin antagonists in salt-sensitive hypertension associated with renal insufficiency. J Cardiovasc Pharmacol 27: 643-651, 1996.
9. Dubin D, Pratt RE, Cooke JP, and Dzau VJ. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1: 13-17, 1989.
10. Fyhrquist F, Saijonmaa O, Metsarinne K, Tikkanen I, Rosenlof K, and Tikkanen T. Raised plasma endothelin-1 concentration following cold pressor test. Biochem Biophys Res Commun 169: 217-221, 1990.
11. 1d-adrenergic receptors. Biochem J 353: 603-610, 2001.
12. Hirata Y, Takagi Y, Fukuda Y, and Muramo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78: 225-228, 1989.
13. Hoang D, Macarthur H, Gardner A, and Westfall TC. Endothelininduced modulation of neuropeptide Y and norepinephrine release from the rat mesenteric bed. Am J Physiol Heart Circ Physiol 283: H1523-H1530, 2002.
14. Ikeda T, Ohta H, Okada M, Kawai N, Nakao R, Siegl PKS, Kobayashi T, Maeda S, Miyauchi T, and Nishikibe M. Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension. Hypertension 34: 514-519, 1999.
15. Kassab S, Miller MT, Novak J, Reckelhoff J, Clower B, and Granger JP. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension 31: 397-402, 1998.
16. Knuepfer MM, Han SP, Trapani AJ, Fok KF, and Westfall TC. Regional hemodynamic and baroreflex effects of endothelin in rats. Am J Physiol Heart Circ Physiol 257: H918-H926, 1989.
17. Koepke JP and DiBona GF. High sodium intake enhances renal and antinatriuretic responses to stress in spontaneously hypertensive rats. Hypertension 7: 357-363, 1985.
18. Koepke JP, Jones S, and DiBona GF. Stress increases renal nerve activity and decreases sodium excretion in Dahl rats. Hypertension 11: 334-338, 1988.
19. Mangiafico RA, Malatino LS, Attinà T, Messina R, and Fiore CE. Exaggerated endothelin release in response to acute mental stress in patients with intermittent claudication. Angiology 53: 383-390, 2002.
20. Miyauchi T and Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61: 391-415, 1999.
21. A-selective antagonist. J Pharmacol Exp Ther 276: 473-481, 1996.
22. Pollock DM, Allcock GH, Krishnan A, Dayton BD, and Pollock JS. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats. Am J Physiol Renal Physiol 278: F279-F286, 2000.
23. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990.
24. Shetty SS, Okada T, Webb RL, Delgrande D, and Lappe RW. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem Biophys Res Commun 191: 459-464, 1993.
25. Tabuchi Y, Nakamaru M, Rakugi H, Nagano M, Mikami H, and Ogihara T. Endothelin inhibits presynaptic adrenergic neurotransmission in rat mesenteric artery. Biochem Biophys Res Commun 161: 803-808, 1989.
26. Tabuchi Y, Nakamaru M, Rakugi H, Nagano M, and Ogihara T. Endothelin enhances vasoconstriction in perfused rat mesenteric arteries. Biochem Biophys Res Commun 159: 1304-1308, 1989.
27. Takayanagi R, Kitazumi K, Takasuki C, Ohnaka K, Aimoto S, Tasaka K, Ohashi M, and Nawata H. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett 282: 103-106, 1991.
28. Treiber FA, Jackson RW, Davis H, Pollock JS, Kapuku G, Mensah GA, and Pollock DM. Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males. Hypertension 35: 722-725, 2000.
29. B receptor in endothelial cells. J Biol Chem 269: 21778-21785, 1994.
30. 1b-adrenoreceptors in rat-1 fibroblasts. J Biol Chem 272: 27330-27337, 1997.
31. Wessale JL, Adler AL, Novak EI, Calzadilla SV, Dayton BD, Marsh KC, Winn M, Jae HS, von Geldern TW, Opgenorth TJ, and Wu-Wong JR. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies. Clin Sci 103, Suppl 48: 112S-117S, 2002.
32. Wiklund NP, Öhlen A, and Cederqvist B. Inhibition of adrenergic neuroeffector transmission by endothelin in the guinea-pig femoral artery. Acta Physiol Scand 134: 311-312, 1988.
33. A selective endothelin receptor antagonists. 1. Discovery of A-127722. J Med Chem 39: 1039-1048, 1996.
34. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.